Showing results (31-40 of 163) with videos related to
Sort By:
Pageof 17
Pharmacoeconomics|February 19, 2021
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of VisionSimone A Huygens, Matthijs M Versteegh, Stefan Vegter, et al.Interactive Cardiovascular and Thoracic Surgery|January 5, 2019
Methods for updating a risk prediction model for cardiac surgery: a statistical primerSabrina Siregar, Daan Nieboer, Michel I M Versteegh, et al.BMC Medical Research Methodology|January 12, 2023
In search of a 'pan-European value set'; application for EQ-5D-3LAyesha Sajjad, Matthijs M Versteegh, Irene Santi, et al.Phytochemistry|April 6, 2019
Quantitative analysis of diverse sporomorph-derived sporopolleninsKlaas G J Nierop, Gerard J M Versteegh, Timothy R Filley, et al.Expert Review of Cardiovascular Therapy|November 5, 2015
The role of multimodality imaging in the selection of patients for aortic valve repairMadelien V Regeer, Michel I M Versteegh, Nina Ajmone Marsan, et al.Health Economics|March 8, 2012
Lead time TTO: leading to better health state valuations?Arthur E Attema, Matthijs M Versteegh, Mark Oppe, et al.Journal of Evolutionary Biology|June 13, 2012
Independence among physiological traits suggests flexibility in the face of ecological demands on phenotypesD M Buehler, F Vézina, W Goymann, et al.Health and Quality of Life Outcomes|January 24, 2015
Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesotheliomaDavid T Arnold, Donna Rowen, Matthijs M Versteegh, et al.Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
Mediastinal restaging: EUS-FNA offers a new perspectiveJouke T Annema, Maud Veseliç, Michel I M Versteegh, et al.Science Advances|January 26, 2024
Climate change, society, and pandemic disease in Roman Italy between 200 BCE and 600 CEKarin A F Zonneveld, Kyle Harper, Andreas Klügel, et al.Pageof 17